Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance
- 15 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (23), 3050-3055
- https://doi.org/10.1161/01.cir.99.23.3050
Abstract
Background—Platelet-rich thrombi are resistant to lysis by tissue plasminogen activator (tPA). Plasminogen activator inhibitor-1 (PAI-1), a rapid inhibitor of tPA, may contribute to arterial thromb...Keywords
This publication has 21 references indexed in Scilit:
- P37 Comparison of a new rapid bedside assay for t-PA with a commercially available ELISA: Possible importance of t-PA antigen determination during thrombolytic therapy for prediction of outcomeFibrinolysis and Proteolysis, 1998
- T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in ratsEuropean Journal of Pharmacology, 1997
- Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.JCI Insight, 1995
- Effect of thrombin on release of plasminogen activator inhibitor-1 from cultured primate arterial smooth muscle cellsThrombosis Research, 1995
- Characterization of the Murine Plasma Fibrinolytic SystemEuropean Journal of Biochemistry, 1994
- A faster-acting and more potent form of tissue plasminogen activator.Proceedings of the National Academy of Sciences, 1994
- Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from plateletsThrombosis Research, 1993
- Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.JCI Insight, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Plasminogen activator inhibitor (PAI‐1) in plasma and plateletsBritish Journal of Haematology, 1988